Originally Published MX
Originally Published MX September/October 2003
With Senate Judiciary Committee hearings recently concluded, the activities of health industry group purchasing organizations (GPOs) will now be a topic of consideration at upcoming joint hearings conducted by the Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ).
GPOs will be the focus of the afternoon session on September 26, which, according to the published agenda, will explore "what current practices or attributes of the industry, if any, raise legitimate antitrust concerns." The hearing will explore product bundling, sole-source suppliers, long-term commitment contracts, and other alleged anticompetitive practices.